Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
PaperCitations, authors & open-access status
Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 608 citations, 2008 year and bronze oa status.
608
Citations
2008
Year
bronze
OA Status